stoxline Quote Chart Rank Option Currency Glossary
  
cbdMD, Inc. (YCBD)
0.8627  -0.019 (-2.19%)    06-12 15:59
Open: 0.8706
High: 0.8857
Volume: 57,162
  
Pre. Close: 0.882
Low: 0.85
Market Cap: 8(M)
Technical analysis
2025-06-12 4:52:55 PM
Short term     
Mid term     
Targets 6-month :  1.14 1-year :  1.29
Resists First :  0.97 Second :  1.11
Pivot price 0.93
Supports First :  0.75 Second :  0.63
MAs MA(5) :  0.89 MA(20) :  0.94
MA(100) :  2.33 MA(250) :  3.37
MACD MACD :  -0.2 Signal :  -0.2
%K %D K(14,3) :  21.7 D(3) :  20.4
RSI RSI(14): 33.2
52-week High :  6.53 Low :  0.52
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ YCBD ] has closed above bottom band by 5.1%. Bollinger Bands are 88.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.89 - 0.89 0.89 - 0.9
Low: 0.84 - 0.84 0.84 - 0.85
Close: 0.85 - 0.86 0.86 - 0.87
Company Description

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.

Headline News

Thu, 22 May 2025
cbdMD (YCBD) Maintains Buy Rating Despite Lowered Price Target | YCBD Stock News - GuruFocus

Thu, 15 May 2025
Earnings call transcript: cbdMD’s Q2 2025 revenue rises, net loss narrows - Investing.com

Fri, 09 May 2025
cbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year 2025 Results - The Globe and Mail

Mon, 21 Apr 2025
cbdMD, Inc. Announces Automatic Conversion Date of Series A Preferred Stock and One for Eight Reverse Split of its Common Stock Immediately Following the Automatic Conversion - Yahoo Finance

Mon, 21 Apr 2025
cbdMD Announces $10.7M Financial Overhaul: Strategic Stock Conversion and 1:8 Reverse Split Coming May 2025 - Stock Titan

Thu, 10 Apr 2025
cbdMD Eliminates $10.7M in Dividend Obligations: Major Financial Restructuring Approved - Stock Titan

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
AMEX
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Shares Out 4 (M)
Shares Float 3 (M)
Held by Insiders 19.1 (%)
Held by Institutions 2.2 (%)
Shares Short 159 (K)
Shares Short P.Month 158 (K)
Stock Financials
EPS -10.9
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.8
Profit Margin -94.2 %
Operating Margin -7.4 %
Return on Assets (ttm) -15.8 %
Return on Equity (ttm) -135.1 %
Qtrly Rev. Growth -15.5 %
Gross Profit (p.s.) 0
Sales Per Share 5.48
EBITDA (p.s.) -1.16
Qtrly Earnings Growth 0 %
Operating Cash Flow -1 (M)
Levered Free Cash Flow 5 (M)
Stock Valuations
PE Ratio -0.08
PEG Ratio 0
Price to Book value 1.07
Price to Sales 0.15
Price to Cash Flow -4.14
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android